Search alternatives:
marked decrease » marked increase (Expand Search)
lasso decrease » largest decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 1 - 20 results of 324 for search '(( third ((((we decrease) OR (nn decrease))) OR (marked decrease)) ) OR ( via lasso decrease ))', query time: 0.63s Refine Results
  1. 1
    Validation of child labor measures using third-party data, households with all children in school.

    Validation of child labor measures using third-party data, households with all children in school. by Guilherme Lichand (11410286)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx by Jianwei Hong (6918776)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Individual and mean EQ-5D VAS scores in the PP-group (0 = baseline, 1 = after the first day of treatment, 2 = after the second day of treatment, 3 = after the third day of treatment, 4 = after the fourth day of treatment, 5 = after all treatments, 35 = at the 30-day follow-up).

    Individual and mean EQ-5D VAS scores in the PP-group (0 = baseline, 1 = after the first day of treatment, 2 = after the second day of treatment, 3 = after the third day of treatmen... by Marcus Persson (20496333)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Correlation analysis of red blood cell-platelet ratio and coagulation indicators.

    Correlation analysis of red blood cell-platelet ratio and coagulation indicators. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Univariate analysis of hospitalized patients.

    Univariate analysis of hospitalized patients. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    The red blood cell-platelet ratio affects prognosis.

    The red blood cell-platelet ratio affects prognosis. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization.

    Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization.

    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM.

    Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Clinical baseline data.

    Clinical baseline data. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Univariate analysis of ICU patients.

    Univariate analysis of ICU patients. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay.

    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set.

    Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Clinical baseline data after PSM.

    Clinical baseline data after PSM. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set.

    Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. by Jie Zhao (49409)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: